Active — Not RecruitingNot Applicable

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults

Hong Kong1,000 participantsStarted 2024-01-01

Plain-language summary

The goal of this clinical trial is to provide a scientific evaluation on the effects of a protocol-driven Pathway to Healthy Aging (Path-HA) Program on promoting the health-related quality of life and functional abilities of older adults who are at risk of accelerated aging in the community. Participants will be randomized to one of the two study arms: 1) the intervention group to receive a 14-week Path-HA care intervention; and 2) the control group with no Path-HA care intervention.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1\) aged 60 or above, * 2\) with at least two risk factors of accelerating aging defined as including reduced physical functioning, malnutrition, depressed mood, loneliness, poor health perception, and presence of geriatric symptoms (e.g. insomnia, pain, etc), based on their health screening results, * 3\) community-dwelling, * 4\) communicable to engage in health education activity. Exclusion Criteria: * 1\) any who is not at or at only one risk factor of accelerating aging, * 2\) any who has problems in communicating with the research team.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial is focused on 'aging well' and measuring health-related quality of life — can you help me understand whether the Pathway to Healthy Aging program addresses the specific health concerns I have right now, or whether it's more of a general wellness approach?
2Since this study is listed as 'active, not recruiting,' does that mean enrollment is closed, and if so, are there similar programs or trials still accepting participants that you could point me toward?
3This trial is listed as Phase NA, which often means it's evaluating a care program or service rather than a drug — can you explain what the Pathway to Healthy Aging care model actually involves day-to-day, and how much time or commitment it would typically require from someone in my situation?
4Because the main thing being measured is health-related quality of life, what does that mean practically — would I be filling out surveys, attending regular check-ins, or making changes to my care routine, and how would we know if it was helping me?
5Compared to whatever standard care or support services I'm already receiving, what would be the main reason you'd suggest I look into a structured aging-well program like this one versus continuing with my current approach?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Health-related quality of life

Timeframe: Changes from baseline to 3-month and 9-month post-intervention

Trial details

NCT IDNCT06105723

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Ageing Well trials